Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mecamylamine”

22 trials

Showing 20 of 22 results

Not applicableStudy completedNCT01223404
What this trial is testing

Nicotinic Modulation of the Default Network

Who this might be right for
Magnetic Resonance ImagingCognitionNicotine+1 more
University of Maryland, Baltimore 21
Large-scale testing (Phase 3)Study completedNCT01197508
What this trial is testing

Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.

Who this might be right for
Major Depressive Disorder
AstraZeneca 696
Early research (Phase 1)Study completedNCT00773812
What this trial is testing

Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders

Who this might be right for
Autistic DisorderPervasive Developmental Disorder
Ohio State University 20
Testing effectiveness (Phase 2)Study completedNCT00319319
What this trial is testing

Nicotinic Receptor Augmentation of SSRI Antidepressants

Who this might be right for
Depressive Disorder
Yale University 60
Large-scale testing (Phase 3)Study completedNCT01180400
What this trial is testing

Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive DisorderDepression
AstraZeneca 295
Testing effectiveness (Phase 2)Study completedNCT00536692
What this trial is testing

Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
CoMentis
Testing effectiveness (Phase 2)Ended earlyNCT01288079
What this trial is testing

Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

Who this might be right for
Major Depressive Disorder
AstraZeneca 145
Not applicableStudy completedNCT01240616
What this trial is testing

Nicotinic Modulation of the Default Network of Resting Brain Function

Who this might be right for
Nicotine Dependence
National Institute on Drug Abuse (NIDA) 43
Testing effectiveness (Phase 2)Study completedNCT00607750
What this trial is testing

Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGF

Who this might be right for
Age-Related Macular Degeneration
CoMentis 60
Large-scale testing (Phase 3)Study completedNCT01152554
What this trial is testing

Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive DisorderMDDDepression
AstraZeneca 813
Large-scale testing (Phase 3)Study completedNCT01157078
What this trial is testing

Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive DisorderDepression
AstraZeneca 319
Large-scale testing (Phase 3)Study completedNCT00563797
What this trial is testing

Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence

Who this might be right for
Alcohol DependenceDepression
Yale University 21
Not applicableStudy completedNCT00455650
What this trial is testing

Study of the Effects of Mecamylamine and Varenicline in Schizophrenia

Who this might be right for
Cognition in Schizophrenia
Massachusetts General Hospital 89
Early research (Phase 1)Study completedNCT01458899
What this trial is testing

Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214

Who this might be right for
Healthy Subjects
AstraZeneca 18
Large-scale testing (Phase 3)Study completedNCT01153347
What this trial is testing

Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive DisorderDepression
AstraZeneca 2,409
Early research (Phase 1)Study completedNCT00018187
What this trial is testing

Combinations of Pharmacologic Smoking Cessation Treatments

Who this might be right for
Smoking
US Department of Veterans Affairs
Post-approval studies (Phase 4)UnknownNCT03914677
What this trial is testing

Mecamylamine for Autonomic Dysreflexia Prophylaxis

Who this might be right for
Spinal Cord Injuries
Wayne State University 5
Early research (Phase 1)Study completedNCT01175564
What this trial is testing

To Investigate Safety, Tolerability and Pharmacokinetics of TC-5214 in Healthy Male Japanese Subjects

Who this might be right for
Healthy
AstraZeneca 48
Testing effectiveness (Phase 2)Study completedNCT00342563
What this trial is testing

Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients

Who this might be right for
Alcoholism
Yale University 136
Testing effectiveness (Phase 2)Study completedNCT00593879
What this trial is testing

Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Targacept Inc. 450
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation